Glasses Online Cheap Change your eyes Each Day »

Pharmaceuticals SUPERNUS progress of Phase IIa SPN812 U. S. clinical trials for ADHD

Supernus Pharmaceuticals Advances SPN812 into Phase IIa U.S. Clinical Trial for ADHD
ROCKVILLE, Md.—-Supernus Pharmaceuticals, Inc. today announced the initiation of a Phase IIa U.S. clinical trial of its product candidate SPN812 for the treatment of ADHD in adults.

This entry was posted by admin on July 13, 2010 at 8:11 am, and is filed under Health Conditions. Follow any responses to this post through RSS 2.0.You can leave a response or trackback from your own site.